Literature DB >> 22632131

Inflammation imaging by silica nanoparticles with antibodies orientedly immobilized.

Tomoaki Shirai1, Hiroshi Kohara, Yasuhiko Tabata.   

Abstract

The objective of this study is to design fluorescent nanoprobes for inflammation imaging. An antibody against CD11b expressed on the surfaces of mouse macrophages (anti-CD11b), was fluorescently labeled. Protein G, which has an ability to bind the Fc region of antibody, was conjugated onto the surface of silica nanoparticles (SiNP). Then, the fluorescent-labeled anti-CD11b was orientedly immobilized to the SiNP surface through the specific protein G-antibody interaction. After the intravenous injection of anti-CD11b orientedly immobilized SiNP to the mouse model of acute interstitial nephritis, unilateral ureteral obstruction (UUO) of one kidney, the fluorescent intensity at the UUO and non-treated, normal kidneys was assessed. The anti-CD11b orientedly immobilized SiNP were accumulated in the UUO kidney to a significantly great extent compared with the normal, non-inflamed kidney. The fluorescence intensity of inflamed kidney 6 and 12 h after injection of the anti-CD11b orientedly immobilized SiNP were significantly higher than that of anti-CD11b randomly immobilized SiNP or free anti-CD11b injection. Histological experiments revealed that the anti-CD11b orientedly immobilized SiNP were associated with macrophages infiltrated into the inflammation site. It is concluded that the anti-CD11b orientedly immobilized SiNP are promising nanoprobes to image the inflammation site at a high intensity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632131     DOI: 10.3109/1061186X.2012.693500

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  9 in total

Review 1.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

Review 2.  Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives.

Authors:  Bo Lin; Ying-Yu Ma; Jun-Wei Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

3.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 4.  Nanomedicines for kidney diseases.

Authors:  Ryan M Williams; Edgar A Jaimes; Daniel A Heller
Journal:  Kidney Int       Date:  2016-06-09       Impact factor: 10.612

Review 5.  Light-Emitting Agents for Noninvasive Assessment of Kidney Function.

Authors:  Jiaguo Huang; Norbert Gretz
Journal:  ChemistryOpen       Date:  2017-07-20       Impact factor: 2.911

Review 6.  A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease.

Authors:  Yanhong Ma; Fanghao Cai; Yangyang Li; Jianghua Chen; Fei Han; Weiqiang Lin
Journal:  Bioact Mater       Date:  2020-06-15

Review 7.  The potential of RNA-based therapy for kidney diseases.

Authors:  Tjessa Bondue; Lambertus van den Heuvel; Elena Levtchenko; Roland Brock
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.651

8.  Preparation of antibody-immobilized gelatin nanospheres incorporating a molecular beacon to visualize the biological function of macrophages.

Authors:  Yu Yoshimoto; Jun-Ichiro Jo; Yasuhiko Tabata
Journal:  Regen Ther       Date:  2020-01-13       Impact factor: 3.419

Review 9.  Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases.

Authors:  J P Jose Merlin; Xiaogang Li
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.